Required.
All cannabis and cannabis products must undergo testing by an Independent Testing Laboratory (ITL) licensed by the Maryland Cannabis Administration (formerly MMCC). A Certificate of Analysis (COA) must be submitted through METRC before sale, transfer, or further processing. Only batches that meet all required analyte limits may proceed.
Required.
COAs must include a quantitative profile of cannabinoids using validated AOAC, NYSDOH, or USP methods. The panel includes:
Required.
All products must be tested for terpenes described in the American Herbal Pharmacopeia (AHP) cannabis inflorescence monograph, including major volatile compounds relevant for inhalation products. Terpenes must be quantified and reported when claimed on product packaging.
Comprehensive panel required.
While Maryland’s program is robust, the following are not explicitly required:
Low Concern: Maryland’s testing rules remain among the strictest in the U.S., with mandatory terpene analysis, stability protocols, visual inspections, and standardized laboratory procedures. A Quality Management Working Group is evaluating further improvements aligned with GMP principles.
Required.
Moisture and aw thresholds are used to control microbial growth and ensure shelf stability.
Maryland Cannabis Administration (MCA)
Formerly: Maryland Medical Cannabis Commission (MMCC)
Website: https://cannabis.maryland.gov
Email: mmcc.labcompliance@maryland.gov
Phone: (410) 487-8100
Maryland Medical Cannabis Commission (October 10, 2020). The Maryland Medical Cannabis Commissions Technical Authority Medical Cannabis Testing
Maryland Cannabis Administration. (2025). COMAR 14.17 and QA working group notes.
Cannabis Cate
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.